"Piracetam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A compound suggested to be both a nootropic and a neuroprotective agent.
| Descriptor ID |
D010889
|
| MeSH Number(s) |
D02.065.064.650 D02.241.081.018.110.650 D03.383.773.812.555
|
| Concept/Terms |
Piracetam- Piracetam
- Pyracetam
- Pirazetam
- 2-Pyrrolidone-N-Acetamide
- Pyramem
Sinapsan- Sinapsan
- Piracetam-RPh
- Piracetam RPh
|
Below are MeSH descriptors whose meaning is more general than "Piracetam".
Below are MeSH descriptors whose meaning is more specific than "Piracetam".
This graph shows the total number of publications written about "Piracetam" by people in this website by year, and whether "Piracetam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Piracetam" by people in Profiles.
-
Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014. J Perinatol. 2017 03; 37(3):296-300.
-
Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons. Sci Rep. 2016 05 11; 6:25705.
-
Treatment of status epilepticus: an international survey of experts. Neurocrit Care. 2013 Apr; 18(2):193-200.
-
Clinical experience with generic levetiracetam in people with epilepsy. Epilepsia. 2011 Apr; 52(4):810-5.
-
Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam. Seizure. 2011 Apr; 20(3):263-5.
-
Intravenous levetiracetam in children with seizures: a prospective safety study. J Child Neurol. 2010 May; 25(5):551-5.
-
High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy. Epilepsia. 2010 Jul; 51(7):1319-22.
-
Levetiracetam for treatment of premenstrual dysphoric disorder: a pilot, open-label study. Arch Womens Ment Health. 2008 Jul; 11(3):207-11.
-
An open-label pilot study of levetiracetam for essential tremor. Clin Neuropharmacol. 2004 Nov-Dec; 27(6):274-7.
-
Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity. Epilepsia. 2003 Oct; 44(10):1280-8.